Dysphagia and Dysphonia Outcomes in SARS CoV-2 (COVID-19) Infection (DYADS Study)

Dysphagia and Dysphonia Outcomes in SARS CoV-2 (COVID-19): A Prospective Observational Cohort Study.

This study examines the presence, severity and natural history of dysphagia and dysphonia in the post-extubation and severely unwell COVID-19 patient.

Inclusion Criteria:

• Patients who have been diagnosed with a positive SARS CoV-2 test.
• Patients who have been diagnosed with dysphonia and/or dysphagia following COVID 19 treatment.
• Patients who require investigation and management for dysphonia and/or dysphagia following COVID 19 treatment.
• Adult patients aged 18 years - 85 years.
• Patients that meet threshold for referral to the joint MDT clinic following screening

Exclusion Criteria:

• Patients who cannot undertake the assessment for dysphonia and/or dysphagia.
• Patients who are being managed with palliative intent.
• Patients with pre-existing dysphonia and/or dysphagia not previously responding to therapy (pre-existing prior to COVID-19 diagnosis).